Cold weather medication delivery needs a plan for possible freezing, as well as keeping a prescription chilled. A package left outside is not automatically ruined. Suspected freezing needs a product-specific review by the dispensing pharmacy before use.
Early November is a good time to settle who will receive the next package. What matters is the medicine's temperature history, including the time between delivery and someone bringing it inside.
Cold weather medication delivery starts before shipping
Planning starts with the prescription's actual storage instructions and the pharmacy's contact details. Temperature-sensitive means heat or cold can affect whether the medicine remains usable.
A clear delivery plan answers four questions:
- When does the pharmacy expect to dispatch the prescription?
- Who will receive it and bring it indoors?
- What happens if tracking shows a delay or failed delivery?
- How can the dispensing pharmacist be reached about a temperature concern?
For a sermorelin prescription, these questions belong with the pharmacy that prepared it. A statement that packaging controls temperature doesn't settle what happened during an unexpected delay. The pharmacy needs the shipment details to make that assessment.
There is a reason to care about the journey. In Chowdhury and colleagues' 2023 mail-transit study, published in the Journal of the American Pharmacists Association, researchers monitored 36 test packages. The lowest recorded temperature was 5.1°F. Those readings describe the study's parcels; they don't show what happened inside a different shipment.
The practical lesson is to preserve the delivery history. A tracking notification and a plan for receiving the parcel make that history easier to establish. They also reduce the chance of a package waiting outside unnoticed.
A cold box cannot tell the whole story
A cold outer box, a frozen packing insert, and frozen medicine are three different observations. None alone describes every temperature the medicine experienced along the route.
A weather report gives the outdoor temperature. Tracking gives locations and times. Neither provides a continuous temperature record beside the medicine. A shipping monitor, when included, can give the pharmacy additional evidence about what happened inside.
Appearance has limits, too. A 2026 laboratory study in the European Journal of Pharmaceutical Sciences examined physical stresses on liquid peptides, short chains of protein building blocks. Its freezing-and-thawing experiments produced tiny particles even in peptide-free liquid in glass containers.
Those were laboratory stress tests, not winter-delivery tests of a patient's prescription. They help explain why the container matters and why a normal appearance cannot settle every quality question.
Ozempic's freeze rule belongs to Ozempic
The Ozempic prescribing information on DailyMed carries “Revised: 5/2026.” It lists 36°F–46°F (2°C–8°C) for an unused Ozempic pen and says Ozempic must not be used if it has frozen.
That is a rule for the branded product. It cannot establish an acceptable shipping exposure for compounded semaglutide. A compounded medicine is prepared by a pharmacy for a prescription. Its formulation—the exact mixture—along with its container and supporting testing can differ.
Compounded semaglutide is different from an FDA-approved product: the formulation offered through Promise is not FDA-approved. A licensed provider may still prescribe — that decision is between you and your doctor.
The distinction matters here because a familiar brand's storage directions cannot replace the dispensing pharmacy's assessment of another preparation. Semaglutide's name alone doesn't answer a shipping question.
Deliveries can also arrive warm
As of November 5, 2026, the day this article was written, FDA reports complaints about warm compounded GLP-1 deliveries. GLP-1 medicines act on a gut-hormone pathway involved in appetite and blood sugar. The page is marked “Content current as of: 10/01/2026.”
FDA recommends against using injectable GLP-1 medicines that arrive warm or with insufficient refrigeration. That is separate from the question of freezing. A cold destination doesn't document the temperature throughout a delivery route, so a shipping concern still needs an answer about the actual package.
What the pharmacy needs after a delay
A temperature excursion means time outside the medicine's stated temperature range. A useful report separates what was observed from what is estimated.
| Detail | What helps the pharmacy assess it |
|---|---|
| Prescription | Medicine name, concentration, lot number, and dispensing label |
| Timeline | Dispatch, delivery, and indoor retrieval times; any tracking delays |
| Packaging | Photos of damage, insulation, and the packing arrangement as received |
| Temperature evidence | Any supplied monitor's reading or record, and observed ice or freezing |
| Unknowns | Missing tracking periods or an uncertain time outside |
A weather forecast estimates the air outside; it isn't a reading from inside the box. A photo can document a cracked container or packing arrangement, but it cannot measure the medicine's remaining strength.
FDA's emergency guidance directs people to storage instructions and a pharmacist, provider, or manufacturer after refrigeration problems during a power outage. The useful principle for a delivery concern is the same: the answer depends on the particular medicine and exposure.
If a sermorelin shipment is in question
The dispensing pharmacy assesses whether the shipment remains usable. The prescriber handles what a possible interruption means for treatment. A delivery problem doesn't create a replacement-dose rule.
For someone prescribed sermorelin, a useful response explains what evidence the pharmacy reviewed and what happens next. If the temperature history is incomplete, that gap is part of the assessment. Another patient's intact delivery cannot settle it.
A printed date also cannot reconstruct a package's journey. Expiration dates and pharmacy use-by dates answer a different question from whether an earlier temperature exposure affected this shipment.
The handoff after delivery
A clear plan identifies who will review a suspected temperature problem, how that team can be reached, and who handles any treatment interruption. It also settles the next delivery's receiving arrangements.
Once a shipment has been assessed, the medicine's own directions govern everyday handling. The peptide-storage guide covers that routine. Taking medicine on a flight involves separate air-travel and storage questions.
At Promise, a licensed provider reviews every request, and not everyone qualifies. If a prescription is issued, a licensed U.S. compounding pharmacy dispenses the medication. A concern about a particular delivery belongs with that dispensing pharmacy and the care team.
